anti-Glucose 6-Phosphatase, Catalytic 3 (G6PC3) Antibodies

G6PC3 encodes the catalytic subunit of glucose-6-phosphatase (G6Pase). Additionally we are shipping G6PC3 Proteins (3) and and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
G6PC3 92579 Q9BUM1
G6PC3 68401 Q6NSQ9
G6PC3 303565 Q6AZ83
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-G6PC3 Antibodies at antibodies-online.com

Showing 10 out of 22 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Delivery Price Details
Cow Rabbit Un-conjugated WB Host: Rabbit Target Name: G6PC3 Sample Type: Hela Antibody Dilution: 1.0ug/ml  G6PC3 is strongly supported by BioGPS gene expression data to be expressed in HeLa Host: Rabbit Target Name: G6PC3 Sample Type: Human Fetal Brain Antibody Dilution: 1.0ug/ml 100 μL 2 to 3 Days
$319.00
Details
Cow Rabbit Un-conjugated WB 100 μL 2 to 3 Days
$289.00
Details
Bat Rabbit Un-conjugated IHC, IHC (p), WB Human Heart: Formalin-Fixed, Paraffin-Embedded (FFPE). This image was taken for the unconjugated form of this product. Other forms have not been tested. 100 μL 11 to 14 Days
$727.83
Details
Cow Rabbit Un-conjugated WB   100 μL 11 to 14 Days
$551.83
Details
Human Rabbit Cy7 IF (p)   100 μL 14 to 21 Days
$416.90
Details
Human Rabbit Cy5.5 IF (p)   100 μL 14 to 21 Days
$416.90
Details
Human Rabbit FITC IF (p)   100 μL 14 to 21 Days
$416.90
Details
Human Rabbit Alexa Fluor 555 IF (p)   100 μL 14 to 21 Days
$416.90
Details
Human Rabbit Alexa Fluor 488 IF (p)   100 μL 14 to 21 Days
$416.90
Details
Human Rabbit Cy3 IF (p)   100 μL 14 to 21 Days
$416.90
Details

More Antibodies against G6PC3 Interaction Partners

Human Glucose 6-Phosphatase, Catalytic 3 (G6PC3) interaction partners

  1. The neutropenia in patients with G6PC3 or G6PT mutations is a metabolite-repair deficiency.

  2. these results indicated that coronin3 is significantly dysregulated in hepatocellular carcinoma tumor tissues, and may exert its function via regulating G6PC3 expression.

  3. mir-122 and its targets G6PC3, ALDOA and CS play roles in the hypoxia responses that regulate glucose and energy metabolism and can serve as hypoxia biomarkers.

  4. classic features of SCN IV found to share an identical inherited canonical splice-site mutation of the G6PC3 gene (c.218+1G>A).

  5. Multilineage involvement of immune system occurs in G6PC3 deficiency in addition to the previously described neutropenia and multiple abnormalities.

  6. G6PC3 defects should be considered in any case of congenital, unexplained neutropenia regardless of the clinical phenotype.

  7. functional characterization of 16 of the 19 known missense mutations in severe congenital neutropenia syndrome caused by glucose-6-phosphatase-beta deficiency;14 missense mutations completely abolish G6Pase-beta activity while the p.S139I and p.R189Q mutations retain 49% and 45%, respectively of wild type activity

  8. Severe congenital neutropenia with autosomal recessive G6PC3 mutations is associated with considerable clinical heterogeneity.

  9. A role for G6PC3 in testicular differentiation and formation.

  10. G6PC3 mutation is associated with severe congenital neutropenia.

  11. Glucose 6 phosphatase catalytic subunit-3 deficiency due to mutation is a heterogenous disorder characterized by severe congenital neutropenia.

  12. Biallelic G6PC3 defects should be considered in patients with autosomal recessive cyclic neutropenia, especially those with typical associated congenital defects.

  13. review of clinical, molecular and genetic aspects of G6PC3 deficiency; loss of function in missense G6PC3 mutations likely results from decreased enzyme stability; the condition can be diagnosed by sequencing G6PC3 gene; a number of G6PC3 ounder mutations are known in various populations and possible genotype-phenotype relationship also exists

  14. 4 ELANE mutations, 11 HAX1 mutations and 2 G6PC3 mutations have been identified in Iranian patients with severe congenital neutropenia.

  15. G6PC3 deficiency may present with inflammatory bowel disease and T cell lymphopenia. The diagnosis should thus be considered in a patient with chronic congenital neutropenia and gastrointestinal symptoms.

  16. G6PC3 mutations cause non-syndromic severe congenital neutropenia.

  17. Three different homozygous G6PC3 mutations were detected in four of the 108 patients/kindreds studied. Parents of affected individuals were all heterozygous for the mutation.

  18. The phenotypic and molecular spectrum in G6PC3 deficiency is wider than previously appreciated. The risk of transition to myelodysplastic syndrome or acute myeloid leukemia may be lower in G6PC3 deficiency compared with other subgroups of SCN

  19. Sequence analyses of G6PC3 in 2 patients with Severe congenital neutropenia revealed two different homozygous mutations

  20. analysis of SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia [case report]

Mouse (Murine) Glucose 6-Phosphatase, Catalytic 3 (G6PC3) interaction partners

  1. Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-beta (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation.

  2. G-CSF improves G6pc3(-/-) neutrophil survival by modulating apoptotic mediators and rectifies function by enhancing energy homeostasis.

  3. in nonapoptotic neutrophils, G6PC3 is essential for normal energy homeostasis. A G6PC3 deficiency prevents recycling of ER glucose to the cytoplasm, leading to neutrophil dysfunction

  4. UGRP/G6Pase is the major glucose-6-phosphatase of physiological importance for glucose homeostasis in vivo.

  5. The absence of G6Pase-beta led to neutropenia

G6PC3 Antigen Profile

Protein Summary

This gene encodes the catalytic subunit of glucose-6-phosphatase (G6Pase). G6Pase is located in the endoplasmic reticulum (ER) and catalyzes the hydrolysis of glucose-6-phosphate to glucose and phosphate in the last step of the gluconeogenic and glycogenolytic pathways. Mutations in this gene result in autosomal recessive severe congenital neutropenia. Multiple transcript variants have been found for this gene, only one of which is expected to express a protein.

Gene names and symbols associated with G6PC3

  • glucose-6-phosphatase catalytic subunit 3 (G6PC3) antibody
  • glucose 6 phosphatase, catalytic, 3 (G6pc3) antibody
  • glucose 6 phosphatase catalytic subunit 3 (G6pc3) antibody
  • 0710001K01Rik antibody
  • AU019276 antibody
  • AU045429 antibody
  • AV128920 antibody
  • AW545836 antibody
  • SCN4 antibody
  • UGRP antibody

Protein level used designations for G6PC3

G-6-Pase 3 , G6Pase 3 , G6Pase-beta , glucose-6-phosphatase 3 , glucose-6-phosphatase catalytic subunit 3 , ubiquitous glucose-6-phosphatase catalytic subunit-related protein , ubiquitously expressed G6Pase catalytic subunit-related protein , glucose-6-phosphatase catalytic subunit-related

GENE ID SPECIES
92579 Homo sapiens
68401 Mus musculus
303565 Rattus norvegicus
369023 Bos taurus
Selected quality suppliers for anti-G6PC3 (G6PC3) Antibodies
Did you look for something else?